Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03994653Completed

Cancer Loyalty Card Study

Role: collaborator

NCT02847715Not ApplicableCompleted

Electronic Patient Self-Reported Outcomes to Improve Cancer Management and Patient Experiences

Role: collaborator

NCT04027205Not ApplicableWithdrawn

Surgery Versus PhysiothErapist-leD Exercise for Traumatic Tears of the Rotator Cuff

Role: collaborator

All 3 trials loaded